![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 37, 38495-38502, September 10, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Strain of Saccharomyces cerevisiae Are Caused by Excessive Vacuolar Ca2+ Uptake Mediated by the Ca2+-ATPase Pmc1p*




**
From the
Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, and Departments of ¶Clinical Chemistry and ||Biochemistry, University Medical School, Peçs H-7624, Hungary
Loss of the major isoform of phosphoglucomutase (PGM) causes an accumulation of glucose 1-phosphate when yeast cells are grown with galactose as the carbon and energy source. Remarkably, the pgm2
strain also exhibits a severe imbalance in intracellular Ca2+ homeostasis when grown under these conditions. In the present study, we examined how the pgm2
mutation alters yeast Ca2+ homeostasis in greater detail. We found that a shift from glucose to galactose as the carbon source resulted in a 2-fold increase in the rate of cellular Ca2+ uptake in wild-type cells, whereas Ca2+ uptake increased 8-fold in the pgm2
mutant. Disruption of the PMC1 gene, which encodes the vacuolar Ca2+-ATPase Pmc1p, suppressed the Ca2+-related phenotypes observed in the pgm2
strain. This suggests that excessive vacuolar Ca2+ uptake is tightly coupled to these defects in Ca2+ homeostasis. An in vitro assay designed to measure Ca2+ sequestration into intracellular compartments confirmed that the pgm2
mutant contained a higher level of Pmc1p-dependent Ca2+ transport activity than the wild-type strain. We found that this increased rate of vacuolar Ca2+ uptake also coincided with a large induction of the unfolded protein response in the pgm2
mutant, suggesting that Ca2+ uptake into the endoplasmic reticulum compartment was reduced. These results indicate that the excessive Ca2+ uptake and accumulation previously shown to be associated with the pgm2
mutation are due to a severe imbalance in the distribution of cellular Ca2+ into different intracellular compartments.
Received for publication, January 26, 2004 , and in revised form, June 18, 2004.
* This work was supported by National Institutes of Health Grant T32 HL07553 (to D. P. A.), American Heart Association Grant 0255121B (to D. M. B.), and Hungarian National Science Foundation Grant T-038144 (to A. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work and should be considered co-first authors.
** To whom correspondence should be addressed: Dept. of Microbiology, BBRB 432/Box 8, 1530 Third Ave., South, The University of Alabama at Birmingham, Birmingham, AL 35294-2170. Tel.: 205-934-6593; Fax: 205-975-5482; E-mail: dbedwell{at}uab.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. L. Penha, L. Mendonca-Previato, J. O. Previato, J. Scharfstein, N. Heise, and A. P. C. d. A. Lima Cloning and characterization of the phosphoglucomutase of Trypanosoma cruzi and functional complementation of a Saccharomyces cerevisiae PGM null mutant Glycobiology, December 1, 2005; 15(12): 1359 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Csutora, A. Strassz, F. Boldizsar, P. Nemeth, K. Sipos, D. P. Aiello, D. M. Bedwell, and A. Miseta Inhibition of phosphoglucomutase activity by lithium alters cellular calcium homeostasis and signaling in Saccharomyces cerevisiae Am J Physiol Cell Physiol, July 1, 2005; 289(1): C58 - C67. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |